|
|
|
Sunday, March 21, 2010 — 1:30 PM, Maryland
|
- Molecular Markers for Diagnosis and Prognosis: What and When
|
|
Moderators:
|
Maria J. Merino, National Cancer Institute, Bethesda, MD and
Celina G. Kleer, University of Michigan, Ann Arbor, MI
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Mark Stoler is a consultant for Merck, Qiagen, Hologic, Roche, Gen-Probe and Ventana Medical. The other speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to view (or print) handout in single page format for the entire meeting.
Note: Any slides will be printed in color.
Click here to view (or print) black and white handout for the entire meeting
Note: Text will be in single page format and any slides will be in 6-per-page format.
Click any blue title below to display and print the handout for individual lecture(s):
| 1:30 | Helpful Markers in the Diagnosis of Prostate Cancer - Jonathan Epstein, The Johns Hopkins Hospital, Baltimore, MD |
| 2:15 | Breast Cancer, The New and The Old - Allen Gown, PhenoPath Laboratories, Seattle, WA |
| 3:00 | Break |
| 3:30 | Mesothelioma Versus Carcinoma: Tempest in a Pleural Teapot? - Jeffrey Myers, University of Michigan, Ann Arbor, MI |
| 4:15 | Intraductal Pancreatic Tumors - David Klimstra, Memorial Sloan-Kettering Cancer Center, New York, NY |
The ASIP Education Committee (Chair, Dr. Martha Furie) met on April 18, 2009 and reviewed the participant critiques of the 2005 - 2008 Companion Meetings. The 2009 critiques were reviewed when they were received in early June. The main educational objective of the previous Companion Meetings has been to demonstrate how advances in the understanding of molecular pathogenesis can be applied to surgical pathology practice. The Committee agreed that this is a continuing educational need and should again be the focus of the 2010 Companion Meeting, with greater emphasis on the impact of molecular pathology. Specific goals should be to inform the audience of the mechanisms of disease pathogenesis and to teach how new understanding of the disease process and new experimental molecular technologies can lead to better diagnostic and prognostic tests. The Committee determined that the potential attendees of the ASIP Companion Meeting at USCAP in 2009, who are predominantly surgical pathologists, could best benefit from strategies to utilize molecular pathology. The Committee selected Dr. Maria Merino and Dr. Celina Kleer as organizers of the 2008 Companion Meeting, both of whom are members of both ASIP and USCAP and are well versed in experimental molecular pathology and diagnostic surgical pathology. Dr. Mark Sobel will be the liaison between the Committee and the organizers to develop the most effective educational program.
The organizers searched the most recent literature for the most important advances in molecular pathology to determine topics for the 2010 companion meeting.
Objective: Pathologists need new strategies to solve key differential diagnostic problems for tumors. The objective of the ASIP Companion Meeting is to demonstrate how advances in the understanding of molecular pathogenesis and molecular diagnostic techniques can be applied to surgical pathology practice.
Goals: Inform attendees about newly discovered molecular mechanisms of disease pathogenesis and new molecular technologies that can lead to better diagnostic and prognostic tests and pathologists' recommendations for appropriate therapies related to cancers of the prostate, breast, pancreas and mesothelium.
|
|
|
|
